Acute Kidney Injury and Fanconi Syndrome Caused by a Red Yeast Rice Supplement  Internal Medicine. 2025;64(16):2472–2477
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39993755

Anemia of Renal Tubular Damage and Mortality in the General Population: The Yamagata (Takahata) study  Internal Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40769895

Bladder cancer: “Breakthrough” treatment that doubles survival rates is approved for NHS patients  BMJ. 2025;390:r1786
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40841124

Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline  BMJ. 2025;390:e082071
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40813129

Dapagliflozin for the Treatment of Collagenofibrotic Glomerulopathy  Internal Medicine. 2025;64(17):2615–2618
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39971290

Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial  BMJ. 2025;390:e085208
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40829896

Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Hematologic, Renal, and Immunologic Disorders. Elsevier Inc.; 2022 
Available from: https://login.smhslibresources.health.wa.gov.au/login?url=https://www.clinicalkey.com.au/#!/browse/book/3-s2.0-C20160033521

The epidemiology of haemodialysis catheter infections in Australia, 2016-20: a prospective cohort study  Medical Journal of Australia. 2025;223(5):248–256
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40703009

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes  New England Journal of Medicine. 2025;393(6):533–543
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40470996

Hinman’s Atlas of Urologic Surgery. Elsevier Inc.; 2026 
Available from: https://login.smhslibresources.health.wa.gov.au/login?url=https://www.clinicalkey.com.au/#!/browse/book/3-s2.0-C20210026651

Immunoglobulin A Nephropathy in a Kidney Transplant Recipient with Kabuki Syndrome  Internal Medicine. 2025;64(17):2619–2625
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40090720

Lower Urinary Tract Symptoms in Men: A Review  JAMA. 2025;334(9):809–821
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40658396

Physiologic Differences in Vital Signs and Urine Tests in Spinal Cord Injury and the Effects on Urinary Tract Infection Diagnosis  American Journal of Physical Medicine and Rehabilitation. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40856495

Post-Transplant Lymphoproliferative Disorder Which Developed 45 Years After Kidney Transplantation  Internal Medicine. 2025;64(16):2466–2471
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39971294

Prostatitis: A Review  JAMA. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40788632

Randomized Prospective Controlled Open-labeled Trial of Cyclosporine with/without Low-dose Oral Corticosteroids in Idiopathic Membranous Nephropathy in Adults with Nephrotic Syndrome  Internal Medicine. 2025;64(17):2541–2548
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39993753

Rituximab as an Effective Treatment for New-onset Evans Syndrome and Systemic Lupus Erythematosus with Lupus Nephritis  Internal Medicine. 2025;64(17):2631–2636
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40090718

Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials Lancet. 2025;406(10505):811–820
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40840478

Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis  Lancet. 2025;406(10504):705–718
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40818851

Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial  Lancet. 2025;406(10504):695–704
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40818850

Successful Resolution of Suspected Red Yeast Rice-induced Nephropathy  Internal Medicine. 2025;64(17):2626–2630
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40090717

Thiazide-induced hyponatraemia: distinguishing hypovolaemic and euvolaemic subtypes to guide management strategies  Internal Medicine Journal. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40831187

Understanding Coproporphyrins and Their Disposition: Coproporphyrinuria is Common, of Diverse Cause, and Rarely Indicates Porphyria  American Journal of Medicine. 2025;138(9):1214–1226.e3
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40228600

Urinary tract infections: New antibiotic for women and girls is approved in UK  BMJ. 2025;390:r1825
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40876896

Use of dipeptidyl peptidase-4 inhibitors is associated with lower risk of severe renal outcomes in pre-dialysis patients with Type 2 diabetes  Journal of Internal Medicine. 2025;298(3):214–227
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40611400